Bisphosphonates in the treatment of osteoporosis

BMJ. 2012 May 22:344:e3211. doi: 10.1136/bmj.e3211.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alendronate / pharmacology
  • Alendronate / therapeutic use*
  • Bone Density Conservation Agents / pharmacology
  • Bone Density Conservation Agents / therapeutic use*
  • Female
  • Hip Fractures / etiology*
  • Hip Fractures / prevention & control*
  • Humans
  • Osteoporosis / complications*
  • Osteoporosis / drug therapy*
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Alendronate